News and Events | Osteal Therapeutics

top of page

JPS vt-x7 treatment.jpg

Pipeline Overview

Pipeline Overview

News

02/07/2023

Osteal Therapeutics Announces First Subject Enrollment in Second Phase 2 Clinical Trial of VT-X7 Combination Product for Treatment of Periprosthetic Joint Infection

12/29/2022

Osteal Therapeutics Announces Leadership Appointments

11/4/22

Osteal Therapeutics, Inc. Completes Enrollment in APEX Phase 2 Clinical Trial of VT-X7 for Periprosthetic Joint Infection

3/8/22

Osteal Therapeutics Closes an Oversubscribed $30 Million Series B Financing to Advance Platform Therapyfor Treatment of Musculoskeletal Infection

1/7/21

JPS is now Osteal Therapeutics®

bottom of page